vimarsana.com

Page 203 - நோய் எதிர்ப்பு சக்தி டோவர்டீ நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Editorial: Incentivized disease

SunStar + February 11, 2021 WHILE Covid-19 is a true story, there might also be some grain of truth to the claim of Cebu Gov. Gwendolyn Garcia that isolation facilities are making money from the pandemic. Garcia said these facilities claim for a single patient P22,449, the maximum reimbursement from the Philippine Health Insurance Corp. (PhilHealth) granted to a beneficiary under the Covid-19 community isolation benefit package (CCIBP). Covid-19 has become an “incentivized disease,” said the governor. “Isolation centers now are lucrative businesses. Because who wanted to spend P22,449 to feed and house a patient within 10 days?” the governor said. Garcia cites, for instance, tuberculosis, a severe illnesses, which is being ignored because the attention has been focused on Covid-19 for reasons that it is covered by the Philhealth package. Under the insurance firm’s Circular 2020-0012, a DOH-certified community isolation unit (CIU) may claim reimbursements

Welcome To IANS Live - LatestNews - Farmers discuss new techniques to improve banana cultivation

Mexico s poor have little luck obtaining opioids intended for palliative care

GeoTrinity/Wikimedia Commons Researchers found that opioid dispensing levels were nearly 10 times higher in Mexico’s wealthiest states than in the poorest. If you’re poor and terminally ill in southern Mexico, there’s far less chance you’ll get the painkillers you need for palliative care than your cousins in more prosperous regions, particularly those pharmacy-rich areas along Mexico–U.S. border, say UCLA researchers and colleagues who studied opioid dispensing levels across the country. What’s more, the researchers’ paper in the journal The Lancet Public Health suggests it’s likely that some of the opioids intended for Mexican citizens are ending up in American pockets.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.